Status:
COMPLETED
Arrhythmias in Post-Myocardial Infarction Patients
Lead Sponsor:
Tampere University
Collaborating Sponsors:
Tays Heart Hospital
GE Healthcare Finland Ltd
Conditions:
Myocardial Infarction
Coronary Artery Disease
Eligibility:
All Genders
Brief Summary
Patients are screened for significant arrhythmias and other possibly significant ECG-patterns directly after discharge and two weeks after myocardial infarction using wearable devices. The home monito...
Detailed Description
Patients with acute myocardial infarction have exceptionally high mortality rates exceeding 10% during the first year post-MI. The incidence of sudden cardiac death after acute myocardial infarction i...
Eligibility Criteria
Inclusion
- Patients treated for myocardial infarction (NSTEMI and STEMI)
Exclusion
- Short life expectancy, unwillingness to participate and need for permanent institutional care
Key Trial Info
Start Date :
June 22 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 28 2019
Estimated Enrollment :
445 Patients enrolled
Trial Details
Trial ID
NCT03231826
Start Date
June 22 2017
End Date
February 28 2019
Last Update
August 12 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tays Heart Hospital
Tampere, Pirkanmaa, Finland, 33540